The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Fitness technology MyFiziq has signed Evolt360. MyFiziq technology is intended to extend the Evolt reach to the hands of consumers at home.

Evolt is a machine based body scanning technology which is supported by health, fitness and wellness companies such as F45, Anytime Fitness, and Life Fitness Distributors.

These companies are looking to provide greater insight into the health of its members and employees.

A low-intensity electrical current is passed through the body, via the feet and hands, and it determines the difference between muscle mass, fat mass, minerals, and water.

The machines cost between $12,000-$20,000 with trained staff to run them and the scans cost between $30-$50 per person depending on the type of scan performed.

MyFiziq uses images from phone to create a realistic 3D avatar of your body which allows for customers to track changes and even buy clothing online.

Co-Founder and Chief Executive Officer of Evolt is excited to show what the future could hold.

“I am extremely confident this is the future of digital dimension, having the ability to place in in the palm of the consumer’s hand and is highly complementary to our offering and strategic decision,” he said.

There are currently more than 4,000 new orders which will begin rolling out soon.

Please find announcement attached here: https://hotcopper.com.au/data/pricesensitive/announcements/ASX/6A926641_MYQ.html

MYQ by the numbers
More From The Market Online

This stock provides Oz’s only HIV self-test kit – and it’s bullish on the budget

Atomo Diagnostics is the only company in Australia that provides TGA-approved HIV self-test kits. It says…

Recce Pharma heading closer to full efficacy data for flagship R327

Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial…
The Market Online Video

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug…

Optiscan agreement with Mayo Clinic aims to expedite robotic surgery

Optiscan Imaging is parterning with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system